The study, published in BMC Genomics, spans five critical developmental stages of the heart, from the neonatal period through adulthood. By combining single-cell RNA sequencing, which captures individual cells, with single-nucleus RNA sequencing, which profiles the genetic activity of nuclei isolated from cells that are difficult to dissociate, the researchers were able to build an integrated picture of the postnatal cardiac landscape. This dual approach is particularly important for heart tissue, where mature cardiomyocytes are large, fragile, and notoriously resistant to standard single-cell preparation techniques.

With this atlas in hand, the team systematically characterized the full cellular panorama of the developing pig heart, documenting how different cell populations emerge, mature, and reorganize as the animal grows. Beyond simply cataloguing cell types, the researchers traced the dynamic changes in gene expression that accompany postnatal cardiac maturation, a period during which the heart transitions from a proliferative, immature state to the hypertrophic, contractile state that defines the adult organ. They also mapped the remodeling of intercellular communication networks—the signaling conversations between cardiomyocytes, fibroblasts, endothelial cells, immune cells, and other residents of the heart—that orchestrate this developmental progression.

The most striking finding emerged from cross-species comparative analysis. When the researchers compared the pig heart atlas with single-cell data from other species, they identified a ventricular cardiomyocyte subpopulation, which they named VCM-LM-SR, characterized by highly active lipid metabolism. This subpopulation is specific to the Wuzhishan miniature pig; it does not appear in the other species examined. The discovery suggests that this breed has evolved, or been selectively bred toward, a distinct metabolic program in its heart muscle cells, one that relies heavily on fatty acid processing as an energy source.

What makes the VCM-LM-SR subpopulation particularly intriguing is its position within the adult cardiac cellular interactome. The researchers found that these lipid-metabolic cardiomyocytes occupy a hub position, meaning they serve as central nodes in the communication network connecting different cell types in the adult heart. Cells that act as hubs typically exert outsized influence over tissue function, coordinating signals and resources across the cellular community. The fact that a metabolically specialized cardiomyocyte subset holds this role hints at a previously unappreciated layer of metabolic regulation in cardiac homeostasis.

The cross-species comparisons also revealed something unexpected about the transcriptional baseline of the Wuzhishan miniature pig heart. The activity of multiple human cardiac disease-related pathways was found to be significantly lower in the pig’s cardiomyocytes compared with the other species examined. In other words, the genetic programs that, when dysregulated, drive heart failure, hypertrophy, and other cardiovascular conditions in humans appear to be running at a quieter baseline level in this donor animal. This finding has direct implications for how researchers interpret data from pig models of cardiac disease, because a lower baseline could mask or alter disease phenotypes in experimental settings.

For the xenotransplantation field, these results carry particular weight. Pig-to-human heart transplantation has moved from theory to clinical reality in recent years, with genetically engineered pig hearts successfully transplanted into human recipients. Understanding the cellular and molecular differences between pig and human hearts is essential for predicting how xenografts will behave after transplantation. The identification of a species-specific lipid-metabolic cardiomyocyte population, and the demonstration that disease-related pathway activity differs between pigs and other species, provides transplant researchers with new molecular features to consider when selecting and engineering donor animals.

The atlas also serves as a foundational resource for studying human cardiac metabolism using large-animal models. Rodent models, while genetically tractable, differ substantially from humans in cardiac physiology, metabolism, and disease susceptibility. Large animals such as pigs bridge this gap far more effectively, and a detailed reference map of the pig heart at single-cell resolution gives researchers a benchmark against which they can measure how cardiac cell states shift in response to disease, diet, surgical intervention, or genetic modification. The developmental dimension of the atlas adds further value, allowing investigators to pinpoint when specific cell populations or communication networks become established during maturation.

Technically, the study showcases the power of integrating single-cell and single-nucleus sequencing data. The researchers employed computational tools including Uniform Manifold Approximation and Projection for visualizing cell populations, differential expression analysis to identify marker genes, transcription factor regulon analysis to infer gene regulatory networks, and Gene Set Variation Analysis to assess pathway activity across cell types and developmental stages. This combination of methods allowed them to move beyond simple cell-type identification toward a functional understanding of how the heart’s cellular ecosystem changes over time and how it differs between species.

The work was funded by the National Key R&D Program Project and the Academician Workstation of the Hainan Academy of Agricultural Sciences, and all animal procedures were approved by the institute’s Animal Care and Use Committee. As genetically engineered pigs edge closer to routine clinical use as organ donors, and as metabolic heart disease continues to rise worldwide, resources like this atlas will become increasingly indispensable. By revealing that even within a single breed, the heart can harbor specialized metabolic cell states unique to that species, the study opens a new window onto the diversity of cardiac biology—and reminds researchers that the choice of model organism matters more, at the single-cell level, than ever before.

Subject of Research: Construction of a single-cell transcriptomic atlas of the Wuzhishan miniature pig heart across postnatal development and cross-species identification of a species-specific lipid-metabolic cardiomyocyte subpopulation.

Article Title: Single-cell atlas of the Wuzhishan miniature pig heart identifies a species-specific lipid-metabolic cardiomyocyte subpopulation

Article References: Xin, W., Li, C., Wang, Z., Han, J., Duan, D., Yuan, J., Qiao, C., Tan, S., Chao, Z., Wang, M., Zhou, S., & Li, X. (2026). Single-cell atlas of the Wuzhishan miniature pig heart identifies a species-specific lipid-metabolic cardiomyocyte subpopulation. BMC Genomics. https://doi.org/10.1186/s12864-026-13335-0

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13335-0

Keywords: Wuzhishan miniature pig, single-cell atlas, cardiomyocytes, lipid metabolism, heart development, xenotransplantation, single-nucleus RNA sequencing, cross-species comparison, cardiac metabolism, BMC Genomics, translational model, cell communication

A cardiac cell atlas is essentially a molecular map of the heart’s cellular communities. The heart is not made solely of muscle cells, although cardiomyocytes are responsible for contraction. It also contains fibroblasts that help form and remodel connective tissue, endothelial cells that line blood vessels, smooth-muscle cells, immune cells, pericytes, and other specialized populations. Each cell type can exist in multiple states, depending on its location, developmental history, mechanical environment, and exposure to injury or disease. An atlas attempts to identify these populations and describe their molecular characteristics, creating a reference against which abnormal tissue can be compared. In practical terms, such a map can help researchers ask not only which cells are present, but also what genes they are expressing, how their states differ, and how cellular neighborhoods change as disease progresses.

The study’s central contribution, according to the supplied record, is integration: the combination of cardiac-cell information across many individuals and across both health and disease. Integration is technically challenging because biological samples are rarely identical. They may come from different people, different anatomical locations, different clinical circumstances, or different stages of illness. Laboratory processing can introduce additional variation, including differences in tissue quality, cell recovery, and measurement conditions. Computational analysis is therefore required to distinguish genuine biological differences from technical noise. Researchers typically use statistical and machine-learning approaches to group cells according to molecular similarity, align comparable populations across samples, and identify signals that recur across individuals. The larger the dataset, the more important these steps become, because a map containing millions of cells can reveal subtle patterns while also magnifying the consequences of analytical bias.

The number of individuals included is particularly important for cardiovascular research. A sample drawn from one or a few hearts may capture a striking biological feature but cannot easily show whether that feature is typical, rare, or specific to a particular patient. Studying 209 people creates more opportunity to observe shared cellular programs as well as person-to-person diversity. Human hearts differ with age, sex, genetic background, medical history, medication exposure, and the presence of cardiovascular risk factors. Disease itself is also heterogeneous: two patients with the same clinical diagnosis may have different molecular changes in their cardiac tissue. A population-scale atlas can provide the reference structure needed to separate broadly conserved disease-associated patterns from changes that appear only in subsets of patients. The supplied information does not specify which clinical groups were included or what individual disease categories were analyzed, so the atlas should be understood primarily as a reported resource rather than as evidence for a particular therapeutic conclusion.

At the cellular level, heart disease is rarely the result of one isolated cell type acting alone. Injury to cardiomyocytes can alter the signals released into surrounding tissue. Fibroblasts may respond by producing extracellular matrix, the protein-rich scaffold that supports cells but can become excessive during fibrosis. Endothelial cells may change their interactions with blood and tissue, while immune cells can amplify or resolve inflammation. These processes form a connected biological system. A cell atlas can help reconstruct that system by examining which cell populations coexist, which molecular pathways are active, and how communication signals differ between healthy and diseased tissue. Such information may eventually guide experiments aimed at determining whether a specific cell state drives disease, protects the heart, or merely reflects damage caused by another process. The atlas itself, however, is a map and not automatically a demonstration of causation.

The technical value of a resource of this size also lies in its potential reuse. Once cardiac cell populations have been catalogued, future studies can compare their own data with the reference atlas. Researchers investigating heart failure, arrhythmia, ischemic injury, cardiomyopathies, or cardiac repair may use such a framework to determine whether their samples contain similar cellular states. Drug-development teams could examine whether an experimental treatment shifts diseased cells toward a molecular profile associated with healthier tissue. Scientists studying human development or regeneration could ask whether particular cell populations resemble earlier or more reparative states. These applications depend on detailed access to the underlying data and on careful matching between samples. Differences in tissue collection, sequencing technology, patient composition, and disease definition can make apparently similar datasets difficult to compare, so an atlas is most powerful when its limitations and provenance are clearly documented.

The phrase “integrated cell atlas” also signals a broader change in biomedical research. Traditional pathology often describes tissue through its visible structure, using microscopy to identify damage, scarring, inflammation, or changes in muscle organization. Molecular atlases add another layer by recording the biological programs active inside individual cells. Instead of treating a diseased heart as a single mass of tissue, researchers can analyze it as a dynamic ecosystem composed of interacting populations. This approach can expose rare cell states that would be diluted in measurements taken from whole tissue. It can also show that cells traditionally assigned to one category may occupy a continuum of states rather than fitting into rigid boxes. Such resolution is valuable because rare or transitional populations may be important during injury, remodeling, or recovery, even when they make up only a small fraction of the total sample.

The reported scale comes with an important interpretive warning. Millions of cells do not necessarily mean millions of independent biological observations, because many cells may come from the same individual. The person, not the individual cell, is generally the key unit for assessing population-level differences. Treating every cell as if it came from a separate person can produce overconfident statistical results, a problem known as pseudoreplication. Robust atlas analysis must therefore account for the nested structure of the data: cells are grouped within tissue samples, and tissue samples are grouped within individuals. The 209-person design provides a valuable foundation for this kind of analysis, but the strength of any specific conclusion will depend on how those participants were selected, how samples were distributed among health and disease groups, and how technical and clinical variables were handled. Those details are not provided in the source record.

For cardiovascular science, the atlas represents a potentially important reference point because the heart’s structure and function emerge from cooperation among many specialized cells. By assembling information from 2.4 million cardiac cells across 209 individuals, the study establishes a scale at which researchers can investigate both common biological patterns and the diversity that distinguishes one patient from another. The work does not, on the available evidence, announce a new drug, a diagnostic test, or a single explanation for heart disease. Its significance is more foundational: it offers a cellular framework that may help future studies interpret how healthy cardiac tissue changes under stress and why disease follows different molecular routes in different people. As medicine moves toward treatments tailored to biological subtypes rather than broad diagnoses alone, comprehensive maps of human tissues could become essential infrastructure for discovering which cells to target, when to intervene, and how to measure recovery.